Concepts (79)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thymoma | 1 | 2015 | 20 | 0.470 |
Why?
|
| Thymus Neoplasms | 1 | 2015 | 39 | 0.460 |
Why?
|
| Adrenal Cortex | 1 | 1999 | 10 | 0.150 |
Why?
|
| Flow Cytometry | 1 | 2020 | 806 | 0.140 |
Why?
|
| Lymphoma, AIDS-Related | 3 | 2005 | 37 | 0.120 |
Why?
|
| Adipose Tissue | 1 | 1999 | 513 | 0.120 |
Why?
|
| Coccidioidomycosis | 1 | 2015 | 12 | 0.120 |
Why?
|
| Sclerosis | 1 | 2015 | 38 | 0.120 |
Why?
|
| Immunophenotyping | 3 | 2020 | 344 | 0.110 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2013 | 70 | 0.100 |
Why?
|
| End Stage Liver Disease | 1 | 2015 | 191 | 0.100 |
Why?
|
| Lymphoma, Non-Hodgkin | 2 | 2005 | 169 | 0.090 |
Why?
|
| Myeloproliferative Disorders | 1 | 2013 | 91 | 0.090 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2013 | 91 | 0.090 |
Why?
|
| Gastrointestinal Diseases | 1 | 2015 | 359 | 0.090 |
Why?
|
| DNA, Viral | 3 | 2005 | 492 | 0.070 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2005 | 87 | 0.060 |
Why?
|
| Simian virus 40 | 2 | 2005 | 194 | 0.060 |
Why?
|
| Plasma Cells | 1 | 2005 | 57 | 0.060 |
Why?
|
| HIV-1 | 3 | 2005 | 484 | 0.060 |
Why?
|
| Middle Aged | 7 | 2015 | 28895 | 0.050 |
Why?
|
| Multiple Myeloma | 1 | 2005 | 203 | 0.050 |
Why?
|
| Adult | 6 | 2015 | 31624 | 0.050 |
Why?
|
| JC Virus | 1 | 2002 | 29 | 0.050 |
Why?
|
| Lymphoma | 1 | 2005 | 331 | 0.050 |
Why?
|
| BK Virus | 1 | 2002 | 60 | 0.050 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2003 | 272 | 0.040 |
Why?
|
| Hodgkin Disease | 1 | 2003 | 305 | 0.040 |
Why?
|
| HIV Infections | 2 | 2003 | 2063 | 0.040 |
Why?
|
| Colonic Neoplasms | 1 | 2002 | 264 | 0.040 |
Why?
|
| Male | 7 | 2015 | 65072 | 0.040 |
Why?
|
| Hyperplasia | 1 | 1999 | 196 | 0.040 |
Why?
|
| Aged | 2 | 2015 | 21386 | 0.040 |
Why?
|
| Functional Laterality | 1 | 1999 | 195 | 0.040 |
Why?
|
| Metaplasia | 1 | 1999 | 217 | 0.030 |
Why?
|
| Humans | 9 | 2020 | 132373 | 0.030 |
Why?
|
| Female | 5 | 2015 | 70809 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 3 | 2005 | 1556 | 0.030 |
Why?
|
| Axilla | 1 | 2013 | 43 | 0.030 |
Why?
|
| Emigrants and Immigrants | 1 | 2015 | 157 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2015 | 238 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2013 | 119 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2013 | 377 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2013 | 332 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2013 | 388 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2013 | 1368 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2002 | 2683 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2005 | 18 | 0.010 |
Why?
|
| Genes, Viral | 1 | 2005 | 181 | 0.010 |
Why?
|
| Ki-67 Antigen | 1 | 2005 | 118 | 0.010 |
Why?
|
| Herpesvirus 8, Human | 1 | 2005 | 50 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2005 | 180 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2005 | 470 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2005 | 437 | 0.010 |
Why?
|
| HIV Protease Inhibitors | 1 | 2003 | 47 | 0.010 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2003 | 38 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2003 | 239 | 0.010 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2005 | 293 | 0.010 |
Why?
|
| Herpesvirus 4, Human | 1 | 2005 | 675 | 0.010 |
Why?
|
| HIV Seronegativity | 1 | 2002 | 30 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 615 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 1723 | 0.010 |
Why?
|
| Base Sequence | 1 | 2005 | 2904 | 0.010 |
Why?
|
| HIV Seropositivity | 1 | 2002 | 129 | 0.010 |
Why?
|
| Viral Load | 1 | 2003 | 410 | 0.010 |
Why?
|
| Gene Expression | 1 | 2005 | 1564 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2005 | 774 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2003 | 566 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2005 | 3780 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2005 | 1303 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2005 | 3422 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 1997 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2003 | 1348 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2002 | 1205 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2005 | 2494 | 0.010 |
Why?
|
| Incidence | 1 | 2003 | 3362 | 0.010 |
Why?
|
| Texas | 1 | 2003 | 3629 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 6457 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2003 | 13020 | 0.000 |
Why?
|